Company · CIK 0001595585 · SIC 2834 — Pharmaceutical Preparations
Tricida, Inc. · TCDA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2019 SForm 4 → | Mar 5, 5:07 pm EST | Gerrit KlaernerPresident and CEO, Director | 8,000 | $23.92 | $191,331 | 140,984 | −5.37% | plan? |
| Feb 28, 2019 SForm 4 → | Mar 1, 7:44 pm EST | Sandra I CoufalDirector, 10% Owner | 2,000 | $23.04 | $46,080 | 17,725 | −10.1% | plan? |
| Feb 25, 2019 SForm 4 → | Feb 27, 6:33 pm EST | Klaus R Dr VeitingerDirector | 12,000 | $22.60 | $271,160 | 89,444 | −11.8% | plan? |
| Feb 25, 2019 MForm 4 → | Feb 27, 6:33 pm EST | Klaus R Dr VeitingerDirector | 4,000 | $0.80 | $3,200 | 43,436 | — | plan? |
| Feb 5, 2019 JForm 4 → | Feb 7, 9:08 pm EST | Sandra I CoufalDirector, 10% Owner | 245,312 | — | — | 0 | — | plan? |
| Feb 5, 2019 JForm 4 → | Feb 7, 6:19 pm EST | Brian M. Isern +210% Owner | 245,312 | — | — | 0 | — | plan? |
| Jan 30, 2019 SForm 4 → | Feb 1, 6:04 pm EST | Sandra I CoufalDirector, 10% Owner | 28 | $20.10 | $563 | 19,725 | −0.14% | plan? |
| Jan 28, 2019 SForm 4 → | Jan 30, 8:17 pm EST | Klaus R Dr VeitingerDirector | 6,000 | $20.31 | $121,880 | 93,444 | −6.03% | plan? |
| Jan 28, 2019 MForm 4 → | Jan 30, 8:17 pm EST | Klaus R Dr VeitingerDirector | 2,000 | $0.80 | $1,600 | 41,436 | — | plan? |
| Jan 28, 2019 SForm 4 → | Jan 30, 8:16 pm EST | Sandra I CoufalDirector, 10% Owner | 1,972 | $20.22 | $39,877 | 19,753 | −9.08% | plan? |
| Jan 25, 2019 SForm 4 → | Jan 28, 7:26 pm EST | Klaus R Dr VeitingerDirector | 6,000 | $20.86 | $125,180 | 95,444 | −5.91% | plan? |
| Jan 25, 2019 MForm 4 → | Jan 28, 7:26 pm EST | Klaus R Dr VeitingerDirector | 2,000 | $0.80 | $1,600 | 41,436 | — | plan? |
| Jan 7, 2019 SForm 4 → | Jan 8, 4:34 pm EST | Dawn Parsell OttoSr VP, Clinical Development | 665 | $23.27 | $15,475 | 0 | −100% | plan? |
| Jan 2, 2019 SForm 4 → | Jan 4, 5:43 pm EST | Claire LockeyChief Dev. Officer and Sr. VP | 684 | $23.59 | $16,136 | 0 | −100% | plan? |
| Dec 27, 2018 SForm 4 → | Dec 31, 7:04 pm EST | Klaus R Dr VeitingerDirector | 2,437 | $23.71 | $57,773 | 97,444 | −2.44% | plan? |
| Dec 27, 2018 MForm 4 → | Dec 31, 7:04 pm EST | Klaus R Dr VeitingerDirector | 997 | $0.80 | $798 | 40,433 | — | plan? |
| Dec 26, 2018 SForm 4 → | Dec 28, 4:22 pm EST | Gerrit KlaernerPresident and CEO, Director | 4,000 | $25.02 | $100,080 | 144,984 | −2.68% | plan? |
| Dec 26, 2018 SForm 4 → | Dec 28, 4:22 pm EST | Sandra I CoufalDirector, 10% Owner | 3,400 | $25.08 | $85,272 | 21,725 | −13.5% | plan? |
| Dec 26, 2018 SForm 4 → | Dec 28, 4:21 pm EST | Klaus R Dr VeitingerDirector | 9,814 | $24.97 | $245,056 | 98,184 | −9.09% | plan? |
| Dec 26, 2018 MForm 4 → | Dec 28, 4:21 pm EST | Klaus R Dr VeitingerDirector | 3,254 | $0.80 | $2,603 | 42,690 | — | plan? |
| Dec 26, 2018 SForm 4 → | Dec 28, 4:20 pm EST | Claire LockeyChief Dev. Officer and Sr. VP | 10,000 | $25.06 | $250,600 | 0 | −100% | plan? |
| Dec 26, 2018 MForm 4 → | Dec 28, 4:20 pm EST | Claire LockeyChief Dev. Officer and Sr. VP | 10,000 | $0.80 | $8,000 | 10,000 | — | plan? |
| Nov 13, 2018 PForm 4 → | Nov 13, 6:54 pm EST | Geoffrey M. ParkerChief Fin. Officer and Sr. VP | 5,000 | $29.72 | $148,600 | 65,000 | +8.33% | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 9:48 pm EDT | Brian M. Isern +910% Owner | 463,158 | $19.00 | $8,800,002 | 463,158 | — | plan? |
| Jul 2, 2018 CForm 4 → | Jul 2, 9:48 pm EDT | Brian M. Isern +910% Owner | 6,612,402 | — | — | 599,379 | — | plan? |
| Jul 2, 2018 AForm 4 → | Jul 2, 9:19 pm EDT | Robert J AlpernDirector | 3,632 | — | — | 179,511 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 9:16 pm EDT | Longitude Capital Partners II, LLC +310% Owner | 131,579 | $19.00 | $2,500,001 | 3,019,734 | +4.56% | plan? |
| Jul 2, 2018 CForm 4 → | Jul 2, 9:16 pm EDT | Longitude Capital Partners II, LLC +310% Owner | 2,888,155 | — | — | 2,888,155 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 9:13 pm EDT | David HirschDirector | 131,579 | $19.00 | $2,500,001 | 3,019,734 | +4.56% | plan? |
| Jul 2, 2018 ACForm 4 → | Jul 2, 9:13 pm EDT | David HirschDirector | 2,891,787 | — | — | 3,632 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 9:11 pm EDT | ORBIMED ADVISORS LLC +1Director, 10% Owner | 368,421 | $19.00 | $6,999,999 | 10,889,280 | +3.50% | plan? |
| Jul 2, 2018 CForm 4 → | Jul 2, 9:11 pm EDT | ORBIMED ADVISORS LLC +1Director, 10% Owner | 10,520,859 | — | — | 10,520,859 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 9:08 pm EDT | David P BonitaDirector, 10% Owner | 368,421 | $19.00 | $6,999,999 | 10,889,280 | +3.50% | plan? |
| Jul 2, 2018 ACForm 4 → | Jul 2, 9:08 pm EDT | David P BonitaDirector, 10% Owner | 10,524,491 | — | — | 3,632 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 9:05 pm EDT | Sandra I CoufalDirector, 10% Owner | 463,158 | $19.00 | $8,800,002 | 463,158 | — | plan? |
| Jul 2, 2018 ACForm 4 → | Jul 2, 9:05 pm EDT | Sandra I CoufalDirector, 10% Owner | 6,616,034 | — | — | 217,199 | — | plan? |
| Jul 2, 2018 AForm 4 → | Jul 2, 9:02 pm EDT | Kathryn E FalbergDirector | 3,632 | — | — | 35,211 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 9:02 pm EDT | Kathryn E FalbergDirector | 31,579 | $19.00 | $600,001 | 31,579 | — | plan? |
| Jul 2, 2018 CForm 4 → | Jul 2, 9:01 pm EDT | Hadley Harbor Master Investors (Cayman) II L.P.10% Owner | 2,138,351 | — | — | 2,138,351 | — | plan? |
| Jul 2, 2018 AForm 4 → | Jul 2, 9:00 pm EDT | Klaus R Dr VeitingerDirector | 3,632 | — | — | 39,436 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 8:58 pm EDT | Steffen PietzkeVP Fin & Chief Acct Officer | 10,527 | $19.00 | $200,013 | 10,527 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 8:55 pm EDT | Jeroen B Van BeekChief Comm Officer and Sr VP | 5,264 | $19.00 | $100,016 | 5,264 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 8:53 pm EDT | Wilhelm StahlChief Tech Officer & Sr. VP | 13,158 | $19.00 | $250,002 | 13,158 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 8:50 pm EDT | Edward J HejlekSVP, General Counsel & Secy. | 13,158 | $19.00 | $250,002 | 13,158 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 8:48 pm EDT | Geoffrey M. ParkerChief Fin. Officer and Sr. VP | 60,000 | $19.00 | $1,140,000 | 60,000 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 2, 8:46 pm EDT | Gerrit KlaernerPresident and CEO, Director | 15,790 | $19.00 | $300,010 | 705,488 | +2.29% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2019 MForm 4 → | Feb 27, 6:33 pm EST | Klaus R Dr VeitingerDirector | 4,000 | — | — | 38,000 | — | |
| Feb 20, 2019 AForm 4 → | Feb 22, 4:19 pm EST | Wilhelm StahlChief Tech Officer & Sr. VP | 60,000 | — | — | 60,000 | — | |
| Feb 20, 2019 AForm 4 → | Feb 22, 4:18 pm EST | Steffen PietzkeVP Fin & Chief Acct Officer | 50,000 | — | — | 50,000 | — | |
| Feb 20, 2019 AForm 4 → | Feb 22, 4:17 pm EST | Geoffrey M. ParkerChief Fin. Officer and Sr. VP | 100,000 | — | — | 100,000 | — | |
| Feb 20, 2019 AForm 4 → | Feb 22, 4:16 pm EST | Dawn Parsell OttoSr VP, Clinical Development | 100,000 | — | — | 100,000 | — | |
| Feb 20, 2019 AForm 4 → | Feb 22, 4:16 pm EST | Claire LockeyChief Dev. Officer and Sr. VP | 30,000 | — | — | 30,000 | — | |
| Feb 20, 2019 AForm 4 → | Feb 22, 4:15 pm EST | Edward J HejlekSVP, General Counsel & Secy. | 60,000 | — | — | 60,000 | — | |
| Feb 20, 2019 AForm 4 → | Feb 22, 4:13 pm EST | Gerrit KlaernerPresident and CEO, Director | 450,000 | — | — | 450,000 | — | |
| Jan 28, 2019 AForm 4 → | Jan 30, 8:23 pm EST | Susannah CantrellSr. VP, Chief Comm. Officer | 210,000 | — | — | 210,000 | — | |
| Jan 28, 2019 MForm 4 → | Jan 30, 8:17 pm EST | Klaus R Dr VeitingerDirector | 2,000 | $0.80 | $1,600 | 42,000 | — | |
| Jan 25, 2019 MForm 4 → | Jan 28, 7:26 pm EST | Klaus R Dr VeitingerDirector | 2,000 | — | — | 44,000 | — | |
| Dec 27, 2018 MForm 4 → | Dec 31, 7:04 pm EST | Klaus R Dr VeitingerDirector | 997 | — | — | 46,000 | — | |
| Dec 26, 2018 MForm 4 → | Dec 28, 4:21 pm EST | Klaus R Dr VeitingerDirector | 3,254 | — | — | 46,997 | — | |
| Dec 26, 2018 MForm 4 → | Dec 28, 4:20 pm EST | Claire LockeyChief Dev. Officer and Sr. VP | 10,000 | — | — | 133,292 | — | |
| Sep 27, 2018 AForm 4 → | Sep 28, 5:26 pm EDT | Dawn Parsell OttoSr VP, Clinical Development | 125,000 | — | — | 250,625 | — | |
| Jul 2, 2018 CForm 4 → | Jul 2, 9:48 pm EDT | Brian M. Isern +910% Owner | 26,317,375 | — | — | 0 | — | |
| Jul 2, 2018 AForm 4 → | Jul 2, 9:19 pm EDT | Robert J AlpernDirector | 13,147 | — | — | 13,147 | — | |
| Jul 2, 2018 CForm 4 → | Jul 2, 9:16 pm EDT | Longitude Capital Partners II, LLC +310% Owner | 11,494,866 | — | — | 0 | — | |
| Jul 2, 2018 ACForm 4 → | Jul 2, 9:13 pm EDT | David HirschDirector | 11,508,013 | — | — | 13,147 | — | |
| Jul 2, 2018 CForm 4 → | Jul 2, 9:11 pm EDT | ORBIMED ADVISORS LLC +1Director, 10% Owner | 41,873,036 | — | — | 0 | — | |
| Jul 2, 2018 ACForm 4 → | Jul 2, 9:08 pm EDT | David P BonitaDirector, 10% Owner | 41,886,183 | — | — | 13,147 | — | |
| Jul 2, 2018 ACForm 4 → | Jul 2, 9:05 pm EDT | Sandra I CoufalDirector, 10% Owner | 26,330,522 | — | — | 13,147 | — | |
| Jul 2, 2018 AForm 4 → | Jul 2, 9:02 pm EDT | Kathryn E FalbergDirector | 13,147 | — | — | 13,147 | — | |
| Jul 2, 2018 CForm 4 → | Jul 2, 9:01 pm EDT | Hadley Harbor Master Investors (Cayman) II L.P.10% Owner | 2,138,351 | — | — | 0 | — | |
| Jul 2, 2018 AForm 4 → | Jul 2, 9:00 pm EDT | Klaus R Dr VeitingerDirector | 13,147 | — | — | 13,147 | — |